Personalized linezolid dosing for drug-resistant TB treatment
Part of Brain & nervous system, Infections clinical trials.
This trial tests whether adjusting the dose of linezolid based on regular blood tests can help people with multidrug-resistant tuberculosis (MDR-TB) tolerate the medication better while on the BPaL or BPaL-M regimen. It aims to reduce side effects and improve treatment success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multidrug-resistant tuberculosis (MDR-TB).
- You are 15 years old or older.
- Your doctor has prescribed linezolid as part of the BPaL or BPaL-M treatment plan.
- You are not pregnant or breastfeeding.
- You do not have severe liver or kidney failure.
- You are not allergic to linezolid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
This trial tests a personalized treatment approach for people with rifampicin-resistant TB that is still sensitive to fluoroquinolones. It aims to find the best combination of medicines based on your specific TB profile.
This trial studies a specific drug combination (BPaLM) for adults with drug-resistant pulmonary (lung) tuberculosis. If you qualify, the goal is to see whether this treatment is effective and safe for your type of infection.
This trial tests a personalized approach to dosing the TB medicine rifampin. By using a computer model based on your individual factors, doctors hope to find the right dose for you, which may improve treatment outcomes.
This study tests whether using a detailed sputum test to guide treatment for drug-resistant tuberculosis (TB) leads to better outcomes. Participants' treatment is tailored based on the specific drug resistance found, which may help them recover faster and reduce side effects.
This study tests new combinations of drugs for treating pulmonary tuberculosis (TB). The goal is to find more effective and safer treatments than the current standard.
Hear when a new Therapeutic Drug Monitoring (TDM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.